Helper-suppressor T-cell leukemia: unusual phenotype controlled with low-dose deoxycoformycin

Area of Science:

• Hematology
• Immunology
• Oncology

Background:

• Chronic T-cell leukemia is a rare hematologic malignancy.
• T-cell surface markers are crucial for classifying leukemia subtypes.
• Understanding aberrant marker expression aids in diagnosis and treatment.

Observation:

• An unusual case of chronic T-cell leukemia presented with simultaneous T4 and T8 surface marker expression on leukemia cells.
• This dual expression is atypical for T-cell malignancies, presenting a diagnostic challenge.

Findings:

• Immunophenotypic analysis confirmed the co-expression of T4 and T8 markers.
• Treatment with low-dose deoxycoformycin led to symptom control.
• Lymphocyte level normalization correlated with changes in adenosine deaminase (ADA) and deoxyadenosine triphosphate/adenosine triphosphate (dATP/ATP) ratios.

Implications:

• This case highlights the importance of comprehensive immunophenotyping in diagnosing T-cell leukemia.
• The findings suggest a potential role for monitoring ADA and dATP/ATP levels in patients treated with deoxycoformycin.
• Further research may elucidate the mechanisms behind dual T4/T8 expression and its therapeutic relevance.